Sanofi has replaced chief executive Paul Hudson with the head of German drugmaker Merck KGaA, after the French drugmaker ...

Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D.

French drugmaker Sanofi ousted CEO Paul Hudson on Thursday ​appointed Belén Garijo, the head of German drugmaker Merck KGaA, ...

Paul Hudson has yet to solve a conundrum raised with him when he took charge of Sanofi in 2019: finding a successor to its ...

The sudden departure stands in contrast to other EU pharma leaders who have been given much longer transitions in recent months, including GSK’s Emma Walmsley and Novo Nordisk’s Lars Fruergaard ...

Sanofi SA SNY on Wednesday decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson's last day as ...

Hudson’s ousting follows a recent string of disappointing pipeline results for Sanofi.

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the French group from Paul Hudson, whose contract will not be renewed.

French pharmaceutical giant Sanofi has removed Paul Hudson as chief executive, thanking him Thursday for "valuable ...